about
Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients.Clinical features of childhood granulomatosis with polyangiitis (wegener's granulomatosis)EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part I: Overall methodology and clinical characterisation.EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria.Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis.Endothelial and smooth muscle cells from abdominal aortic aneurysm have increased oxidative stress and telomere attrition.Failure of anti tumor-derived endothelial cell immunotherapy depends on augmentation of tumor hypoxia.High levels of PROM1 (CD133) transcript are a potential predictor of poor prognosis in medulloblastomaDexamethasone prophylaxis in pediatric open heart surgery is associated with increased blood long pentraxin PTX3: potential clinical implications.Oct-4+/Tenascin C+ neuroblastoma cells serve as progenitors of tumor-derived endothelial cells.Relative responsiveness of condition specific and generic health status measures in juvenile idiopathic arthritisGenetic Inhibition Of The Ubiquitin Ligase Rnf5 Attenuates Phenotypes Associated To F508del Cystic Fibrosis Mutation.Intratumoral diversity of telomere length in individual neuroblastoma tumors.Development and validation of a clinical index for assessment of long-term damage in juvenile idiopathic arthritis.Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.Relationship between damage accrual, disease flares and cumulative drug therapies in juvenile-onset systemic lupus erythematosus.Beta-cell autoimmunity in pediatric celiac disease: the case for routine screening?Consensus procedures and their role in pediatric rheumatology.Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis.The PRINTO criteria for clinically inactive disease in juvenile dermatomyositisTP53 codon 72 polymorphism may predict early tumour progression in paediatric pilocytic astrocytoma.Usefulness and safety of double endoscopy in children with gastroesophageal reflux and respiratory symptoms.An international consensus survey of diagnostic criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis.Smoke exposure, wheezing, and asthma development: a systematic review and meta-analysis in unselected birth cohorts.Polymorphisms in the osteopontin promoter affect its transcriptional activity.Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial.2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation CollA Meta-Analysis to Estimate the Placebo Effect in Randomized Controlled Trials in Juvenile Idiopathic Arthritis.2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation CollIntra-articular corticosteroids versus intra-articular corticosteroids plus methotrexate in oligoarticular juvenile idiopathic arthritis: a multicentre, prospective, randomised, open-label trial.2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric RheumatologyCoarse vs. fine needle aspiration biopsy for the assessment of diffuse liver disease from hepatitis C virus-related chronic hepatitis.Insulin pump failures in Italian children with Type 1 diabetes: retrospective 1-year cohort study.Activating Killer Immunoglobulin Receptors and HLA-C: a successful combination providing HIV-1 controlDiagnostic potential of hepcidin testing in pediatrics.Retinopathy screening in patients with type 1 diabetes diagnosed in young age using a non-mydriatic digital stereoscopic retinal imaging.Development and validation of a preliminary definition of minimal disease activity in patients with juvenile idiopathic arthritis.Image-defined risk factors in unresectable neuroblastoma: SIOPEN study on incidence, chemotherapy-induced variation, and impact on surgical outcomes.The impact of age on serum allergen-specific IgE to inhaled molecular components.Morbidity and Risk Factors of Laparoscopic-Assisted Ileostomies in Children With Ulcerative Colitis.
P50
Q33386883-047E61C7-074C-45F3-B203-E32FA8570823Q33696589-51C25FDE-DF8E-4229-ABA9-FA94AB420554Q34109962-B3F11962-DFBF-4CA4-8D85-38EEBBD4D8FEQ34111632-33BC2617-55C7-4FE3-A5BD-C63FADE5B537Q34196828-6338D148-F831-47F6-B2E7-C7638C0F8990Q34238949-81665002-665B-452D-AF76-81C4C3C5EF32Q34786452-C21DE878-903F-42ED-A4F6-918B244B73CDQ34977386-D7F7D6F2-E4B9-4512-9950-861FD897C97DQ35110197-455CD561-C253-49AE-9991-D0601BE9F936Q35348365-B0A24AF7-5031-4331-A1EC-0B81F9D0BD75Q35555214-8D6D0218-22D9-49DA-B3D5-5C3BA804D0E1Q35693982-DB18B963-E168-44D4-AEF0-1EE8C868923BQ35781332-986E0AAF-5295-46FA-8A0F-6DD3A0EC3123Q36178472-A2DEFEB1-9919-475E-8FD0-5A4D68BA4794Q36517235-3F2B1DDA-1295-4796-922A-483A6E12361EQ36581673-3B3368CA-BB4B-4F04-A6E7-C1BAA61F2C42Q37067089-2C64D84A-E728-40AC-87A1-6C607A6A07C2Q37155925-1A1C41C8-337A-411B-9CA4-49720BE2E539Q37285430-2B509EE2-A2E6-425C-B5B7-255C14AA3439Q37293030-2ED0D0BF-352F-4A94-B96A-C45EF695FAA9Q37565322-6F189DFE-0E7B-4609-A223-072DD04A56B1Q37643029-A7B72369-AAC8-493C-9354-7BBE945CFBCBQ37834144-3501CCAB-87B2-4421-95F6-B58263B8AABEQ38197567-9392BF40-F00F-4F23-95E6-22FF9365E73AQ38335491-F2C82638-29F5-4E63-A5A9-40A2D8DEC0C9Q38374642-9D49A303-D2AE-4076-856E-08B35D61FC55Q38575277-949647FE-18AF-47EC-8B5B-6BE8D0BD443EQ38691413-60C1825E-F890-4D07-9DB4-E028F279BA08Q38729149-967C0DAF-DED1-4122-AD9E-F8FE509163B8Q38761381-AAAA990D-0657-44B2-8260-B05806F0C4F8Q38849148-8E470276-1F31-42AB-993A-A2C58976533CQ38924073-AF35981A-DAA5-4498-AC46-795B3933DF9FQ39154985-0BE6B15D-4271-4E81-9B81-F49EE3F2988AQ39208685-C471A932-01F4-4A38-AC67-C9B2310D0B63Q39462117-17D024DC-7F63-469F-8BFE-009C4B688189Q40002220-1BB0FEEE-5BED-4D62-A35F-62F6E1882C21Q40064593-7B11057A-196B-4F0A-BD1D-87384F56D5BCQ40229142-0A7DEBD6-E370-48C7-90C6-86A19F9D9F31Q40353454-BB58D2FC-7D66-4E97-AA50-419E98E717D2Q40361653-5635A62C-337A-4C77-A080-6B6E44E6C8F9
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Angela Pistorio
@ast
Angela Pistorio
@en
Angela Pistorio
@es
Angela Pistorio
@nl
type
label
Angela Pistorio
@ast
Angela Pistorio
@en
Angela Pistorio
@es
Angela Pistorio
@nl
prefLabel
Angela Pistorio
@ast
Angela Pistorio
@en
Angela Pistorio
@es
Angela Pistorio
@nl
P106
P21
P31
P496
0000-0002-6895-8720